SAN JOSE, CA, Vantis Vascular today announced the successful closing of $10 million Series B-1 preferred financing.
Vantis Vascular, a pioneering medical technology company founded by physicians with a passion to revolutionize vascular interventions, today announced the successful closing of $10 million Series B-1 preferred financing, following a raise of $30 million to date from high-net-worth individuals and National Institute of Health grants.
Vantis Vascular is a medical technology company dedicated to revolutionizing vascular interventions. Founded by physicians, Vantis develops performance-driven technologies that aim to provide faster, safer and more effective treatments. With a focus on innovation and patient-centric solutions, Vantis is committed to advancing the field of interventional cardiology and improving patient outcomes worldwide.
(c) by Massinvestor, Inc. For contact info, please check out our about page.